Daikaffil Chemicals India Limited has informed the stock exchanges that its board meeting is scheduled to be held on Thursday, May 28, 2026. The primary agenda of the meeting is to consider and approve the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026, along with the report of the statutory auditors.

Agenda for the Meeting

The board will deliberate on the financial performance of the company for the specified period. Additionally, the directors may discuss any other business with the permission of the chair and the majority of directors present at the meeting.

Trading Window Closure

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct, the trading window for the quarter and financial year ended March 31, 2026, remains closed. The window closed on April 1, 2026, and shall reopen after the expiry of 48 hours from the declaration of the financial results.

Key Details

Daikaffil chemicals India Limited has filed its quarterly compliance certificate with BSE Limited under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company submitted the mandatory certificate on April 7, 2026, through its Company Secretary and Compliance Officer Jay Patel. The filing fulfills the regulatory requirements under SEBI's depositories and participants regulations framework.

Registrar Confirmation

The certificate was issued by MUFG Intime India Private Limited (formerly Link Intime India Private Limited), the company's registrar and share transfer agent. MUFG Intime confirmed compliance with dematerialisation processes during the quarter through Senior Vice President Ashok Shetty on April 3, 2026.

Key Confirmations by Registrar

• Securities received from depository participants for dematerialisation were properly confirmed to depositories
• All security certificates were mutilated and cancelled after due verification
• Depository names were substituted in the register of members within prescribed timelines
• Securities comprised in certificates have been listed on relevant stock exchanges

Company Information

Daikaffil Chemicals India Limited operates with its registered office located at E/4, M.I.D.C., Tarapur Boisar-401506, Dist-Palghar, Maharashtra. The company maintains its corporate office in Mumbai and holds CIN number L24114MH1992PLC067309.

The quarterly certificate submission ensures the company remains compliant with SEBI's regulatory framework governing depositories and participants, maintaining transparency in its securities handling processes.